Search

The ruthenium(II) compounds cis-[Ru(bpy) 2 (4-bzpy)(CO)](PF 6 ) 2 (I) and cis-[Ru(bpy) 2 (4-bzpy)(Cl)](PF 6 ) (II) (4-bzpy=4-benzoylpyridine, bpy=2,2'-bipyridine) were synthesized and characterized by spectroscopic and electrochemical techniques. The crystal structure of II was determined by X-ray diffraction. The photochemical behavior of I in aqueous solution shows that irradiation with ultraviolet light (365nm) releases both CO and 4-bzpy leading to the formation of the cis-[Ru(bpy) 2 (H 2 O) 2 ] 2+ ion as identified by NMR and electronic spectroscopy. Carbon monoxide release was confirmed with the myoglobin method and by gas chromatographic analysis of the headspace. CO release was not observed when aqueous I was irradiated with blue light (453nm). Changes in the electronic and 1 H NMR spectra indicate that I undergoes photoaquation of 4-bzpy to form cis-[Ru(bpy) 2 (CO)(H 2 O)] 2+ . Blue light irradiation of aqueous II released the coordinated 4-bzpy to give the cis-[Ru(bpy) 2 (H 2 O)(Cl)] 2+ ion. When the latter reaction was carried out in the presence of the nucleobase guanine, Ru-guanine adducts were formed, indicating that the metal containing photoproduct may also participate in biologically relevant reactions. The photochemical behavior of I indicates that it can release either CO or 4-bzpy depending on the wavelength chosen, a feature that may have therapeutic application., (Copyright © 2017 Elsevier Inc. All rights reserved.)

The ruthenium(II) compounds cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 (I) and cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6) (II) (4-bzpy=4-benzoylpyridine, bpy=2,2'-bipyridine) were synthesized and characterized by spectroscopic and electrochemical techniques. The crystal structure of II was determined by X-ray diffraction. The photochemical behavior of I in aqueous solution shows that irradiation with ultraviolet light (365nm) releases both CO and 4-bzpy leading to the formation of the cis-[Ru(bpy)2(H2O)2]2+ ion as identified by NMR and electronic spectroscopy. Carbon monoxide release was confirmed with the myoglobin method and by gas chromatographic analysis of the headspace. CO release was not observed when aqueous I was irradiated with blue light (453nm). Changes in the electronic and 1H NMR spectra indicate that I undergoes photoaquation of 4-bzpy to form cis-[Ru(bpy)2(CO)(H2O)]2+. Blue light irradiation of aqueous II released the coordinated 4-bzpy to give the cis-[Ru(bpy)2(H2O)(Cl)]2+ ion. When the latter reaction was carried out in the presence of the nucleobase guanine, Ru-guanine adducts were formed, indicating that the metal containing photoproduct may also participate in biologically relevant reactions. The photochemical behavior of I indicates that it can release either CO or 4-bzpy depending on the wavelength chosen, a feature that may have therapeutic application.

Abstract: The [Ru(dppb)(mbt)2], mbt=2-mercaptobenzothiazole, complex, isolated from the reaction of the mer-[RuCl3(dppb)(OH2)] complex with the 2,2′-dithiobis(benzothiazole), mbts, was characterized by spectroscopic and electrochemical techniques (E 1/2 =0.78V versus NHE) and its structure was determined by crystal X-ray analysis. The structural analysis suggests that the S–S bond of the mbts ligand is cleaved, thus forming two four-membered chelate rings coordinated to the ruthenium through the N,S-donor atoms of the mbt reduced ligands, with an average bite angle of 67.295(11)°. The 1H and 13C NMR signals observed for mbts ligand coordinated to the metal center, the changes in the vibrational spectra, and the appearance of a MLCT band in the electronic spectrum of the complex point for the reduced state of the ruthenium metal center, RuII. These reducing processes are suggested to be due to the methanol interference, which is observed to be strongly affected by N-methylmorpholine. The cytochrome c electrochemistry was analyzed by using the SAMs formed by the mbts and the [Ru(dppb)(mbt)2] complex on gold, with only the former presenting electroactivity. [Copyright &y& Elsevier]

Abstract: Ruthenium(II) carbonyl complexes containing triarylphosphines and hybrid ligands PPh2-X (X= o-dimethylaniline – P–N, o-pyridine – P-Py, or o-anisole – P–O) were synthesized and characterized. Six new complexes with the formula cis,trans-[RuCl2(CO)(PPh2-X)(PR3)] (X= o-dimethylaniline, R=Ph 1a; X= o-pyridine, R=Ph 2a; X= o-anisole, R=Ph 3a; X= o-dimethylaniline, R= p-tol 1b; X= o-pyridine, R= p-tol 2b; and X= o-anisole, R= p-tol 3b) were obtained by starting from the appropriate precursors, [RuCl2(CO)(DMF)(PPh3)2] or [RuCl2(CO)(DMF)(P{p-tol}3)2]. The two chlorine atoms are in cis position to each other, and the monophosphine (PPh3 or P{p-tol}3) is in trans position to the nitrogen or oxygen of the PPh2-X ligand. The synthesized complexes were characterized by 1D–1H, 31P{1H} and 2D-correlations HMBC 31P–1H NMR, vibrational spectroscopy, elemental analysis, and X-ray diffraction structural determination (for complexes 1a, 2a·CH2Cl2 , 3a, and 3b·CH2Cl2 ). Only the complexes containing the P–O ligand (3a and 3b) reacted with carbon monoxide (at 1atm and room temperature). The NMR (31P{1H}, 1H) data was compatible with carbon monoxide coordination at the OCH3 position, which led to the formation of dicarbonyl complexes [RuCl2(CO)2(P–O)(PR3)] (R=Ph 4a or p-tol 4b), and proved the hemilabile behavior of the P–O ligand. In addition, the complexes underwent isomerization in solution when exposed to ambient light, and the products were analyzed by 31P{1H} NMR. The X-ray structures and the chemical shift in the 31P NMR spectra were correlated and discussed. [Copyright &y& Elsevier]